Literature DB >> 24440875

Radiotherapy planning for glioblastoma based on a tumor growth model: improving target volume delineation.

Jan Unkelbach1, Bjoern H Menze, Ender Konukoglu, Florian Dittmann, Matthieu Le, Nicholas Ayache, Helen A Shih.   

Abstract

Glioblastoma differ from many other tumors in the sense that they grow infiltratively into the brain tissue instead of forming a solid tumor mass with a defined boundary. Only the part of the tumor with high tumor cell density can be localized through imaging directly. In contrast, brain tissue infiltrated by tumor cells at low density appears normal on current imaging modalities. In current clinical practice, a uniform margin, typically two centimeters, is applied to account for microscopic spread of disease that is not directly assessable through imaging. The current treatment planning procedure can potentially be improved by accounting for the anisotropy of tumor growth, which arises from different factors: anatomical barriers such as the falx cerebri represent boundaries for migrating tumor cells. In addition, tumor cells primarily spread in white matter and infiltrate gray matter at lower rate. We investigate the use of a phenomenological tumor growth model for treatment planning. The model is based on the Fisher-Kolmogorov equation, which formalizes these growth characteristics and estimates the spatial distribution of tumor cells in normal appearing regions of the brain. The target volume for radiotherapy planning can be defined as an isoline of the simulated tumor cell density. This paper analyzes the model with respect to implications for target volume definition and identifies its most critical components. A retrospective study involving ten glioblastoma patients treated at our institution has been performed. To illustrate the main findings of the study, a detailed case study is presented for a glioblastoma located close to the falx. In this situation, the falx represents a boundary for migrating tumor cells, whereas the corpus callosum provides a route for the tumor to spread to the contralateral hemisphere. We further discuss the sensitivity of the model with respect to the input parameters. Correct segmentation of the brain appears to be the most crucial model input. We conclude that the tumor growth model provides a method to account for anisotropic growth patterns of glioma, and may therefore provide a tool to make target delineation more objective and automated.

Entities:  

Mesh:

Year:  2014        PMID: 24440875     DOI: 10.1088/0031-9155/59/3/747

Source DB:  PubMed          Journal:  Phys Med Biol        ISSN: 0031-9155            Impact factor:   3.609


  15 in total

1.  Analyzing magnetic resonance imaging data from glioma patients using deep learning.

Authors:  Bjoern Menze; Fabian Isensee; Roland Wiest; Bene Wiestler; Klaus Maier-Hein; Mauricio Reyes; Spyridon Bakas
Journal:  Comput Med Imaging Graph       Date:  2020-12-02       Impact factor: 4.790

2.  Personalized Radiotherapy Design for Glioblastoma: Integrating Mathematical Tumor Models, Multimodal Scans, and Bayesian Inference.

Authors:  Jana Lipkova; Panagiotis Angelikopoulos; Stephen Wu; Esther Alberts; Benedikt Wiestler; Christian Diehl; Christine Preibisch; Thomas Pyka; Stephanie E Combs; Panagiotis Hadjidoukas; Koen Van Leemput; Petros Koumoutsakos; John Lowengrub; Bjoern Menze
Journal:  IEEE Trans Med Imaging       Date:  2019-02-27       Impact factor: 10.048

3.  Evaluation of current clinical target volume definitions for glioblastoma using cell-based dosimetry stochastic methods.

Authors:  L Moghaddasi; E Bezak; W Harriss-Phillips
Journal:  Br J Radiol       Date:  2015-07-03       Impact factor: 3.039

4.  Subject-specific Brain Tumor Growth Modelling via An Efficient Bayesian Inference Framework.

Authors:  Yongjin Chang; Gregory C Sharp; Quanzheng Li; Helen A Shih; Georges El Fakhri; Jong Beom Ra; Jonghye Woo
Journal:  Proc SPIE Int Soc Opt Eng       Date:  2018-03-02

5.  A modality-adaptive method for segmenting brain tumors and organs-at-risk in radiation therapy planning.

Authors:  Mikael Agn; Per Munck Af Rosenschöld; Oula Puonti; Michael J Lundemann; Laura Mancini; Anastasia Papadaki; Steffi Thust; John Ashburner; Ian Law; Koen Van Leemput
Journal:  Med Image Anal       Date:  2019-03-22       Impact factor: 8.545

6.  Modeling the propagation of tumor fronts with shortest path and diffusion models-implications for the definition of the clinical target volume.

Authors:  Thomas Bortfeld; Gregory Buti
Journal:  Phys Med Biol       Date:  2022-07-25       Impact factor: 4.174

7.  Deep Learning for Reaction-Diffusion Glioma Growth Modeling: Towards a Fully Personalized Model?

Authors:  Corentin Martens; Antonin Rovai; Daniele Bonatto; Thierry Metens; Olivier Debeir; Christine Decaestecker; Serge Goldman; Gaetan Van Simaeys
Journal:  Cancers (Basel)       Date:  2022-05-20       Impact factor: 6.575

8.  Malignancy probability map as a novel imaging biomarker to predict malignancy distribution: employing MRS in GBM patients.

Authors:  Manijeh Beigi; Kevan Ghasemi; Parvin Mirzaghavami; Mohammadreza Khanmohammadi; Hamidreza SalighehRad
Journal:  J Neurooncol       Date:  2018-03-14       Impact factor: 4.130

9.  Biphasic modeling of brain tumor biomechanics and response to radiation treatment.

Authors:  Stelios Angeli; Triantafyllos Stylianopoulos
Journal:  J Biomech       Date:  2016-03-30       Impact factor: 2.712

10.  Towards patient-specific modeling of brain tumor growth and formation of secondary nodes guided by DTI-MRI.

Authors:  Stelios Angeli; Kyrre E Emblem; Paulina Due-Tonnessen; Triantafyllos Stylianopoulos
Journal:  Neuroimage Clin       Date:  2018-08-31       Impact factor: 4.881

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.